Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Induction of the Immunoproteasome Subunit Lmp7 Links Proteostasis and Immunity in α-Synuclein Aggregation Disorders.

Ugras S, Daniels MJ, Fazelinia H, Gould NS, Yocum AK, Luk KC, Luna E, Ding H, McKennan C, Seeholzer S, Martinez D, Evans P, Brown D, Duda JE, Ischiropoulos H.

EBioMedicine. 2018 May;31:307-319. doi: 10.1016/j.ebiom.2018.05.007.

2.

KRAS Engages AGO2 to Enhance Cellular Transformation.

Shankar S, Pitchiaya S, Malik R, Kothari V, Hosono Y, Yocum AK, Gundlapalli H, White Y, Firestone A, Cao X, Dhanasekaran SM, Stuckey JA, Bollag G, Shannon K, Walter NG, Kumar-Sinha C, Chinnaiyan AM.

Cell Rep. 2016 Feb 16;14(6):1448-1461. doi: 10.1016/j.celrep.2016.01.034. Epub 2016 Feb 4.

3.

Targeting the MLL complex in castration-resistant prostate cancer.

Malik R, Khan AP, Asangani IA, Cieślik M, Prensner JR, Wang X, Iyer MK, Jiang X, Borkin D, Escara-Wilke J, Stender R, Wu YM, Niknafs YS, Jing X, Qiao Y, Palanisamy N, Kunju LP, Krishnamurthy PM, Yocum AK, Mellacheruvu D, Nesvizhskii AI, Cao X, Dhanasekaran SM, Feng FY, Grembecka J, Cierpicki T, Chinnaiyan AM.

Nat Med. 2015 Apr;21(4):344-52. doi: 10.1038/nm.3830. Epub 2015 Mar 30.

4.

Utility of RNA-seq and GPMDB protein observation frequency for improving the sensitivity of protein identification by tandem MS.

Shanmugam AK, Yocum AK, Nesvizhskii AI.

J Proteome Res. 2014 Sep 5;13(9):4113-9. doi: 10.1021/pr500496p. Epub 2014 Jul 28.

5.

The central role of EED in the orchestration of polycomb group complexes.

Cao Q, Wang X, Zhao M, Yang R, Malik R, Qiao Y, Poliakov A, Yocum AK, Li Y, Chen W, Cao X, Jiang X, Dahiya A, Harris C, Feng FY, Kalantry S, Qin ZS, Dhanasekaran SM, Chinnaiyan AM.

Nat Commun. 2014;5:3127. doi: 10.1038/ncomms4127.

6.

The role of sarcosine metabolism in prostate cancer progression.

Khan AP, Rajendiran TM, Ateeq B, Asangani IA, Athanikar JN, Yocum AK, Mehra R, Siddiqui J, Palapattu G, Wei JT, Michailidis G, Sreekumar A, Chinnaiyan AM.

Neoplasia. 2013 May;15(5):491-501.

7.

Characterization of KRAS rearrangements in metastatic prostate cancer.

Wang XS, Shankar S, Dhanasekaran SM, Ateeq B, Sasaki AT, Jing X, Robinson D, Cao Q, Prensner JR, Yocum AK, Wang R, Fries DF, Han B, Asangani IA, Cao X, Li Y, Omenn GS, Pflueger D, Gopalan A, Reuter VE, Kahoud ER, Cantley LC, Rubin MA, Palanisamy N, Varambally S, Chinnaiyan AM.

Cancer Discov. 2011 Jun;1(1):35-43. doi: 10.1158/2159-8274.CD-10-0022. Epub 2011 Jun 1.

8.

Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.

Brenner JC, Ateeq B, Li Y, Yocum AK, Cao Q, Asangani IA, Patel S, Wang X, Liang H, Yu J, Palanisamy N, Siddiqui J, Yan W, Cao X, Mehra R, Sabolch A, Basrur V, Lonigro RJ, Yang J, Tomlins SA, Maher CA, Elenitoba-Johnson KS, Hussain M, Navone NM, Pienta KJ, Varambally S, Feng FY, Chinnaiyan AM.

Cancer Cell. 2011 May 17;19(5):664-78. doi: 10.1016/j.ccr.2011.04.010. Erratum in: Cancer Cell. 2013 Apr 15;23(4):557.

9.

Abacus: a computational tool for extracting and pre-processing spectral count data for label-free quantitative proteomic analysis.

Fermin D, Basrur V, Yocum AK, Nesvizhskii AI.

Proteomics. 2011 Apr;11(7):1340-5. doi: 10.1002/pmic.201000650. Epub 2011 Feb 17.

10.

Development of selected reaction monitoring-MS methodology to measure peptide biomarkers in prostate cancer.

Yocum AK, Khan AP, Zhao R, Chinnaiyan AM.

Proteomics. 2010 Oct;10(19):3506-14. doi: 10.1002/pmic.201000023.

11.
12.

Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry.

Yocum AK, Chinnaiyan AM.

Brief Funct Genomic Proteomic. 2009 Mar;8(2):145-57. doi: 10.1093/bfgp/eln056. Epub 2009 Mar 11. Review.

13.

Comparison of MS(2)-only, MSA, and MS(2)/MS(3) methodologies for phosphopeptide identification.

Ulintz PJ, Yocum AK, Bodenmiller B, Aebersold R, Andrews PC, Nesvizhskii AI.

J Proteome Res. 2009 Feb;8(2):887-99. doi: 10.1021/pr800535h.

14.

A spectral clustering approach to MS/MS identification of post-translational modifications.

Falkner JA, Falkner JW, Yocum AK, Andrews PC.

J Proteome Res. 2008 Nov;7(11):4614-22. doi: 10.1021/pr800226w. Epub 2008 Sep 19.

PMID:
18800783
15.

Coupled global and targeted proteomics of human embryonic stem cells during induced differentiation.

Yocum AK, Gratsch TE, Leff N, Strahler JR, Hunter CL, Walker AK, Michailidis G, Omenn GS, O'Shea KS, Andrews PC.

Mol Cell Proteomics. 2008 Apr;7(4):750-67. doi: 10.1074/mcp.M700399-MCP200. Epub 2008 Feb 26.

16.

Analysis of the zebrafish proteome during embryonic development.

Lucitt MB, Price TS, Pizarro A, Wu W, Yocum AK, Seiler C, Pack MA, Blair IA, Fitzgerald GA, Grosser T.

Mol Cell Proteomics. 2008 May;7(5):981-94. doi: 10.1074/mcp.M700382-MCP200. Epub 2008 Jan 22.

17.

EBP, a program for protein identification using multiple tandem mass spectrometry datasets.

Price TS, Lucitt MB, Wu W, Austin DJ, Pizarro A, Yocum AK, Blair IA, FitzGerald GA, Grosser T.

Mol Cell Proteomics. 2007 Mar;6(3):527-36. Epub 2006 Dec 12.

18.

Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.

Yocum AK, Busch CM, Felix CA, Blair IA.

J Proteome Res. 2006 Oct;5(10):2743-53.

PMID:
17022645
19.

Effect of immunoaffinity depletion of human serum during proteomic investigations.

Yocum AK, Yu K, Oe T, Blair IA.

J Proteome Res. 2005 Sep-Oct;4(5):1722-31.

PMID:
16212426
20.

Novel lipid hydroperoxide-derived hemoglobin histidine adducts as biomarkers of oxidative stress.

Yocum AK, Oe T, Yergey AL, Blair IA.

J Mass Spectrom. 2005 Jun;40(6):754-64.

PMID:
15827957

Supplemental Content

Loading ...
Support Center